ArticleCancer immunology, immunotherapy : CII2020

TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients.

Maya Dadiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.